A dynamic field at the intersection of obstetrics and pharmacology, dedicated to understanding the impact of medications on the developing fetus during pregnancy. This specialized branch of medicine delves into the complex web of maternal-fetal pharmacokinetics and pharmacodynamics, aiming to optimize therapeutic outcomes while minimizing potential risks. Physicians and researchers in this field navigate the intricate landscape of drug safety during pregnancy, addressing the unique physiological changes in both the mother and the developing fetus. Focused on ensuring the well-being of both patients, Obstetrical Fetal Pharmacology explores the delicate balance between treating maternal conditions and safeguarding fetal development. As advancements in medical science continue to unfold, this field plays a crucial role in shaping evidence-based guidelines for prescribing medications during pregnancy, providing invaluable insights for healthcare professionals to make informed decisions. In the realm of Obstetrical Fetal Pharmacology, rigorous research is conducted to comprehend the nuances of drug transfer across the placenta, assess potential teratogenic effects, and discern the impact of medication on fetal growth and development. Studying the safety profiles of various drugs becomes paramount, considering the vulnerabilities of the developing fetus to external influences. Additionally, this field scrutinizes the intricate interplay between maternal health conditions, such as hypertension or diabetes, and the pharmacological interventions required to manage them without compromising fetal well-being. The evolution of personalized medicine further contributes to tailoring drug regimens based on individual patient characteristics, fostering a more precise and nuanced approach to obstetric care. Obstetrical Fetal Pharmacology is an evolving discipline that not only strives to advance our understanding of pharmacotherapy during pregnancy but also seeks to empower healthcare providers with the knowledge needed to navigate the complexities of maternal-fetal medicine.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia